Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalent, Inc. (CTLT)  
$56.20 0.33 (0.58%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 207,851,000
Market Cap: 11.68(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.86 - $59.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,000 1,000
Total Buy Value $0 $0 $49,980 $49,980
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 387 387 11,063 116,582
Total Sell Value $21,749 $21,749 $512,581 $11,151,362
Total People Sold 1 1 12 18
Total Sell Transactions 1 1 25 69
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 821
  Page 6 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Classon Rolf A Director   –       •      –    2022-10-27 4 A $0.00 $0 D/D 4,149 36,328     -
   Greisch John J Director   –       •      –    2022-10-27 4 A $0.00 $0 D/D 4,149 16,880     -
   Morel Donald E Jr Director   –       •      –    2022-10-27 4 A $0.00 $0 D/D 4,149 58,462     -
   Flynn Karen Director   –       •      –    2022-10-27 4 A $0.00 $0 D/D 4,149 17,346     -
   Hawkeswood Thomas W Pres. Pharma Prod Delivery Div   •       –      –    2022-10-10 4 AS $77.46 $72,038 D/D (930) 5,364 -10%     
   Santiago Karen Murphy VP & Chief Accounting Officer   •       –      –    2022-09-19 4 A $0.00 $0 D/D 2,421 2,421     -
   Flynn Karen Director   –       •      –    2022-09-15 3 IO $0.00 $0 D/D 0 12,952 -40%     
   Flynn Karen Director   –       •      –    2022-09-15 4 A $0.00 $0 D/D 245 13,197     -
   Hopson Ricky Pres. Clinical Dev Supply Div   •       –      –    2022-08-31 4 AS $89.59 $198,531 D/D (2,216) 17,095 -44%     
   Riley Michael A. Pres. Bio Product Delivery Div   •       –      –    2022-08-26 4 AS $104.07 $259,238 D/D (2,491) 6,592 -52%     
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2022-08-26 4 AS $104.07 $170,571 D/D (1,639) 23,988 -52%     
   Hunt Patricia Pres. Consumer Health Div   •       –      –    2022-08-25 4 S $103.04 $34,931 D/D (339) 9,315 54%     
   Schmidt Kay A SVP, Enterprise Functions   •       –      –    2022-08-25 4 S $103.04 $136,116 D/D (1,321) 17,388 54%     
   Maselli Alessandro President & CEO   •       •      –    2022-08-25 4 S $103.04 $478,724 D/D (4,646) 41,190 54%     
   Gunther Scott SVP, Quality & Reg. Affairs   •       –      –    2022-08-25 4 S $103.04 $189,594 D/D (1,840) 25,627 54%     
   Hopson Ricky Pres. Clinical Dev Supply Div   •       –      –    2022-08-25 4 S $103.04 $156,312 D/D (1,517) 19,311 54%     
   Arnold Jonathan SVP & Chief Commercial Ofcr   •       –      –    2022-08-25 4 S $103.04 $39,567 D/D (384) 55,958 54%     
   Fasman Steven L EVP & Chief Admin Officer   •       –      –    2022-08-25 4 S $103.04 $495,725 D/D (4,811) 61,853 54%     
   Gargiulo Mario SVP Global Ops Biologics   •       –      –    2022-08-25 4 S $103.04 $163,421 D/D (1,586) 6,354 54%     
   Hawkeswood Thomas W Pres. Pharma Prod Delivery Div   •       –      –    2022-08-25 4 S $103.04 $69,140 D/D (671) 6,294 54%     
   Gennadios Aristippos Group Pres. Pharma & Consumer   •       –      –    2022-08-25 4 S $103.04 $169,501 D/D (1,645) 86,769 54%     
   Boerman Manja Pres. BioModalities Division   •       –      –    2022-08-25 4 S $103.04 $339,620 D/D (3,296) 16,640 54%     
   Castellano Thomas P SVP, Chief Financial Officer   •       –      –    2022-08-25 4 S $103.04 $145,699 D/D (1,414) 20,099 54%     
   Carletti Lorenzo SVP Global Ops Ph & Cons Hlth   •       –      –    2022-08-25 4 S $103.04 $106,440 D/D (1,033) 4,985 54%     
   Pravda Ricardo SVP & Chief HR Officer   •       –      –    2022-08-25 4 S $103.04 $180,011 D/D (1,747) 20,008 54%     
  821 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us